Atlas Trials

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Clinical trial NCT00243594 · COMPLETED

Trial details

NCT number
NCT00243594
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Melanoma Stage III or IV
Start date
1999-09-01
Primary completion
2009-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.